Tab. I.
Characteristics | SARS-CoV | SARS-CoV-2 |
---|---|---|
First occurrence | Nov. 16, 2002 in Foshan, Guangdong | Dec. 07, 2019 in Wuhan, Hubei |
Global alert declaration (WHO) | March 13, 2003 | Jan 30, 2020 |
Pandemic declaration (WHO) | - | March 11th, 2020 |
Genome | RNA | RNA |
Length, bp | 29,751 | 29,811 |
Mutation rate RNA | 0.80-2.38 × 10-3 subs/site/year | 7.8 × 10-4 subs/site/year |
Moderate | High | |
Mode of transmission | Respiratory droplet | Respiratory droplet |
Contact | Contact | |
- | Fecal-oral (?) | |
- | Airborne (?) | |
Incubation period (median) | 4.0 days (95% CI: 3.6-4.4) | 5.1 days (95% CI: 4.5-5.8) |
R0 | 2-4 | 1.4-7.23 |
Asymptomatic rate | 2.3-13% | 5-8% |
Case fatality rate | 9.6% | 5.1% |
SARS-CoV: severe acute respiratory syndrome; SARS-CoV-2: coronavirus disease-2019; bp: base pairs; R0: basic reproduction number; CI: confidence interval.